Pharma News

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the U.S. Fo...

Amphastar Pharmaceuticals will buy Baqsimi from Eli Lilly and Co in a deal worth up to $1.08 billion as it aims to boost its portfolio of low blood sugar drugs, the two companies said on Monday. ...

Xortx Therapeutics has received Orphan Drug designation for its Xorlo (oxypurinol) drug to treat autosomal dominant polycystic kidney disease, the most common form of polycystic kidney disease. ...

Based on years of research, the gene-therapy treatment for glaucoma developed with a biotech company can help prevent vision lo
ss.

A flurry of deals suggests that drug firms favour buying their way out of trouble.

Dr. Reddy's Laboratories Ltd. , along with its subsidiaries together referred to as "Dr. Reddy's", today announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent gen...

Researchers from the University of Michigan have found that an extra copy of a gene in Down syndrome patients causes improper development of neurons in mice.

More research needed to determine if sleep medications prevent, delay Alzheimer’s.

Immunotherapy, particularly CAR T-Cell treatment for cancer, is extending the lives of many patients. But sometimes the therapy randomly migrates to places it shouldn’t go, tucking into the lungs...

AbbVie ABBV announced that the FDA has approved the label expansion of its migraine drug Qulipta (atogepant) at 60mg dose to include the prevention of chronic migraine in adults. ...

Acadia’s Daybue begins commercial launch as the first approved treatment for Rett Syndrome, following a recent FDA approval.

Israeli biotech company Gamida Cell has secured approval from the US Food and Drug Administration (FDA) for Omisirge (omidubicel-onlv), an allogeneic cell therapy. ...